Skip to main content

Palmitoyl Tetrapeptide-7 vs DSIP

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Palmitoyl Tetrapeptide-7

Palmitoyl Tetrapeptide-7 is an anti-inflammatory peptide that reduces IL-6 secretion. Combined with Palmitoyl Tripeptide-1, it forms Matrixyl 3000, addressing both collagen production and inflammation.

Full details →

DSIP

Delta Sleep-Inducing Peptide is a neuropeptide that promotes delta wave sleep, the deepest and most restorative phase of the sleep cycle.

Full details →

Side-by-Side Comparison

AspectPalmitoyl Tetrapeptide-7DSIP
MechanismSuppresses interleukin-6 (IL-6) production, reducing inflammation that contributes to skin aging. The anti-inflammatory effect complements collagen-stimulating peptides.Modulates sleep-wake cycles by affecting sleep spindles and delta rhythms. May also influence stress hormones and have analgesic properties.
Typical DosageTopical: Usually combined with Palmitoyl Tripeptide-1 at similar concentrations (2-4%) in the Matrixyl 3000 complex.Typical dosing: 100-300mcg administered 30 minutes before sleep. Some protocols use it cyclically.
AdministrationTopical application with other anti-aging actives. The palmitoyl group enhances delivery into the skin.Subcutaneous or intramuscular injection before bedtime. Some users report better results with cyclical use.
Side EffectsExcellent tolerability profile. Anti-inflammatory properties may actually soothe sensitive skin.May cause grogginess upon waking, vivid dreams, or temporary headaches.
Best For

Key Differences

Unique to Palmitoyl Tetrapeptide-7:

Unique to DSIP:

Detailed Analysis

DSIP and Palmitoyl Tetrapeptide-7 are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose DSIP for Recovery & Healing, Sleep Quality. Choose Palmitoyl Tetrapeptide-7 for Skin Health & Aesthetics.

Ready to Learn More?